Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway

Xiyong Yu1, Shu-Guang Lin, Xiao R Huang

  • 1The Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou 510080, China.

Insights

Macrophage migration inhibitory factor (MIF) activates the MEK-ERK pathway in macrophages, leading to increased matrix metalloproteinase-9 (MMP-9) expression and activation, contributing to atherosclerotic plaque destabilization.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Signaling

Background:

  • Macrophage migration inhibitory factor (MIF) is implicated in atherosclerotic plaque destabilization.
  • MIF's role may involve the activation of matrix metalloproteinase-9 (MMP-9).

Purpose of the Study:

  • To elucidate the signaling mechanism by which MIF induces MMP-9 expression and activation.
  • To investigate the specific mitogen-activated protein kinase (MAPK) pathways involved in MIF-induced MMP-9 regulation in murine macrophages.

Main Methods:

  • Utilized RAW264.7 murine macrophage cell line.
  • Assessed activation of ERK1/2, JNK, and p38 MAPKs by MIF.
  • Employed specific MAPK inhibitors (PD98059, SB203589, SP600125) and dominant-negative constructs (DN-MEK, DN-ERK).

Main Results:

  • MIF activated ERK1/2 and, to a lesser extent, JNK, but not p38 MAPK.
  • Inhibition of ERK (PD98059) or JNK (SP600125) pathways significantly reduced MIF-induced MMP-9 expression and activation.
  • Overexpression of dominant-negative MEK or ERK abolished MIF-induced MMP-9.
  • Constitutive MEK expression induced basal MMP-9 but did not enhance MIF's effect.

Conclusions:

  • MIF activates the MEK-ERK MAPK pathway to induce MMP-9 expression and activation in murine macrophages.
  • The MEK-ERK pathway is essential for MIF-mediated MMP-9 regulation.
  • This signaling axis is a key mechanism linking MIF to processes involved in atherosclerotic plaque instability.